2seventy bio, Inc. (TSVT) DCF Valuation

2seventy bio, Inc. (TSVT) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

2seventy bio, Inc. (TSVT) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment choices with the 2seventy bio, Inc. (TSVT) DCF Calculator! Explore real financial data, adjust growth projections and expenses, and instantly observe how these modifications affect the intrinsic value of 2seventy bio, Inc. (TSVT).


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 44.3 248.1 54.5 91.5 100.4 125.4 156.5 195.5 244.1 304.8
Revenue Growth, % 0 460.15 -78.03 67.81 9.72 24.88 24.88 24.88 24.88 24.88
EBITDA -329.2 -131.4 -297.2 -251.4 -206.4 -113.6 -141.8 -177.1 -221.2 -276.2
EBITDA, % -743.15 -52.98 -545.03 -274.74 -205.62 -90.6 -90.6 -90.6 -90.6 -90.6
Depreciation 12.6 13.2 16.4 11.5 10.3 21.7 27.1 33.9 42.3 52.8
Depreciation, % 28.42 5.32 30.08 12.6 10.25 17.33 17.33 17.33 17.33 17.33
EBIT -341.8 -144.6 -313.6 -262.9 -216.7 -114.9 -143.5 -179.2 -223.8 -279.4
EBIT, % -771.57 -58.29 -575.11 -287.34 -215.87 -91.66 -91.66 -91.66 -91.66 -91.66
Total Cash -133.6 -127.6 362.2 266.3 217.0 37.3 46.5 58.1 72.5 90.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 7.4 10.7 17.0 21.0 13.4
Account Receivables, % 16.76 4.31 31.17 22.91 13.36
Inventories 133.6 127.6 -114.1 13.6 .0 16.6 20.8 25.9 32.4 40.4
Inventories, % 301.55 51.43 -209.31 14.91 0 13.27 13.27 13.27 13.27 13.27
Accounts Payable 20.4 7.2 6.0 7.2 6.0 18.5 23.1 28.9 36.1 45.0
Accounts Payable, % 46.03 2.88 11.05 7.88 6 14.77 14.77 14.77 14.77 14.77
Capital Expenditure -59.8 -22.3 -19.6 -22.8 -13.9 -46.0 -57.5 -71.8 -89.7 -112.0
Capital Expenditure, % -134.92 -8.97 -35.9 -24.97 -13.81 -36.73 -36.73 -36.73 -36.73 -36.73
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -344.7 -166.4 -296.4 -262.9 -216.7 -113.6 -141.9 -177.2 -221.3 -276.4
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -512.5 -186.0 -65.3 -404.7 -200.3 -150.9 -177.3 -221.4 -276.5 -345.3
WACC, % 7.56 7.56 7.41 7.56 7.56 7.53 7.53 7.53 7.53 7.53
PV UFCF
SUM PV UFCF -918.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -352
Terminal Value -6,367
Present Terminal Value -4,428
Enterprise Value -5,347
Net Debt 182
Equity Value -5,529
Diluted Shares Outstanding, MM 49
Equity Value Per Share -112.20

What You Will Get

  • Pre-Filled Financial Model: 2seventy bio, Inc.'s actual data enables precise DCF valuation.
  • Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers.
  • Instant Calculations: Automatic updates ensure you see results as you make changes.
  • Investor-Ready Template: A refined Excel file designed for professional-grade valuation.
  • Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts.

Key Features

  • 🔍 Real-Life TSVT Financials: Pre-filled historical and projected data for 2seventy bio, Inc. (TSVT).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate 2seventy bio’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize 2seventy bio’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Access the ready-to-use Excel file with 2seventy bio, Inc.'s (TSVT) financial data.
  • Customize: Adjust forecasts, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations update in real-time.
  • Test Scenarios: Create multiple projections and compare outcomes instantly.
  • Make Decisions: Use the valuation results to guide your investment strategy.

Why Choose 2seventy bio, Inc. (TSVT)?

  • Innovative Solutions: Benefit from cutting-edge therapies and advancements in biotechnology.
  • Proven Expertise: Backed by a team of seasoned professionals with extensive industry experience.
  • Patient-Centric Approach: Focused on delivering treatments that significantly improve patient outcomes.
  • Commitment to Quality: Adherence to the highest standards in research and development ensures reliability.
  • Collaborative Partnerships: Engaging with leading organizations to enhance research and therapeutic options.

Who Should Use This Product?

  • Investors: Accurately assess the fair value of 2seventy bio, Inc. (TSVT) before making investment choices.
  • CFOs: Utilize a high-quality DCF model for financial reporting and analysis related to 2seventy bio, Inc. (TSVT).
  • Consultants: Easily customize the template for valuation reports tailored to clients in the biotech sector.
  • Entrepreneurs: Acquire knowledge of financial modeling practices employed by leading biotech firms.
  • Educators: Implement it as a teaching resource to illustrate valuation techniques in the life sciences industry.

What the Template Contains

  • Pre-Filled Data: Includes 2seventy bio, Inc.'s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze 2seventy bio, Inc.'s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.